""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_component_original"	"response_component"	"cell_ontology_id"	"proterm_and_extra"	"pro_ontology_id"	"fully_qualified_response_component"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"baseline_time"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"additional_exposure_material"	"comparison"	"cohort"	"publication_reference"	"publication_year"	"signature_source"	"signature_source_url"	"comments"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subm_obs_id"	"uniq_obs_id"	"response_comp_cnt"	"exposure_material_1"	"exposure_material_2"	"signature_file"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	""	""	""	""	"pathogen"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	"vaccine"	"vaccine"	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	""	"file"
"role"	""	""	""	"tissue"	"observed"	"cell_biomarker"	"observed"	"observed"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"pathogen"	"background"	"background"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"observed"	"vaccine"	"vaccine"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response component (original)"	"response component (cell subset)"	"cell ontology ID"	"cell type PRO and extra terms"	"protein ontology ID"	"all response components in signature"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"baseline time"	"target pathogen"	"vaccine year"	"exposure material (name)"	"additional exposure material"	"comparison"	"cohort"	"publication reference (PMID)"	"publication year"	"signature source figure, table or text section"	"signature source url"	"comments and additional details"	"Grode et al. (2013) Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial. Vaccine PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835' target='_blank'>23290835</a>"	"cohort"	"min. age"	"max. age"	"age units"	"ID of observation within its submission"	"Uniq ID of observation within submission type"	"response component count"	"exposure material 1 (VO)"	"exposure material 2 (VO)"	"signature response component (cell types) file"
""	"hipc_ctf_23290835_3"	"2013.02"	"hipc_ctf_23290835_3"	"peripheral blood mononuclear cell"	"triple-positive (IFN-gamma TNF-a IL-2) CD4 T cells"	"CD4-positive, alpha-beta T cell"	"CL_0000624"	"& IFNG+, TNF-a+, IL-2+"	"PR:000000017, PR:000000134, PR:000001379"	"CD4-positive, alpha-beta T cell & IFNG+, TNF-a+, IL-2+"	"cell type frequency"	"up"	"none"	"29"	"Days"	"time of vaccination (first dose)"	"mycobacterium bovis BCG"	""	"BCG vaccine; VPM1002"	""	"VPM1002-3 vs BCG vaccine"	"adults (18-55)"	"23290835"	"2013"	""	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=23290835"	"adults"	"18"	"55"	"years"	"3"	"59"	"1"	"VO_0000771"	"VO_0003131"	"hipc_ctf_sig_23290835_3.txt"
